As one of the settled enterprises in the Traditional Chinese Medicine Science and Technology Industrial Park of Co-operation between Guangdong and Macao，it is convenient to obtain the service center of the Pharmaceutical Administration Bureau of Macao SAR (ISAF) (hereinafter referred to as “the service center”) to provide policy, technical consultation and guidance services to enterprises who are interested in applying for registration of traditional Chinese patent medicines in Macao in the process of application, registration and approval.
On June 12, with the help of the service center, we had face-to-face communication and guidance with the ISFA on the 1.1 new Chinese medicine Tangning Tongluo Tablets which to treat diabetes retinopathy, and New Chinese medicine for syndrome ——Huanglian Jiedu Pills， those our company are researching. Carried out in-depth communication and exchange on cross-border import and export of hospital preparations and declaration of IND.We introduced the product development, current progress and later plan to the head of ISAF,director of Chinese Medicine Department and reviewers.Our preliminary research work was fully affirmed, and the questions raised were effectively answered, which provided valuable advice for the later research work and drug declaration.
Figure: Face to face guidance meeting site
In the future, we will actively communicate with ISAF to strengthen exchanges and obtain guidance,let the registration report less detours,and constantly promote the progress of research and development.
